• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    6/23/23 12:20:19 PM ET
    $APLD
    $APOG
    $AVDL
    $BBLN
    Finance: Consumer Services
    Finance
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $APLD alert in real time by email

    Gainers

    • Kidpik Corp. (NASDAQ:PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.
    • Conformis, Inc. (NASDAQ:CFMS) shares rose 91.3% to $0.2969 after the company agreed to be acquired by restor3d, a leading personalized 3D-printed orthopedic company, for a purchase price of $2.27 per share in cash.
    • SCWorx Corp. (NASDAQ:WORX) gained 62% to $0.5800.
    • OncoSec Medical Incorporated (NASDAQ:ONCS) shares jumped 41.3% to $0.2969 after gaining around 8% on Thursday.
    • Surgalign Holdings, Inc. (NASDAQ:SRGA) shares gained 40.9% to $0.2839. Surgalign received NASDAQ delisting notice following Chapter 11 filing.
    • Nuvve Holding Corp. (NASDAQ:NVVE) shares rose 34% to $0.6101 after the company launched Astrea AI forecasting for Nordic Energy market.
    • Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) gained 24.7% to $0.2749.
    • Smith & Wesson Brands, Inc. (NASDAQ:SWBI) shares climbed 17% to $13.15 as the company reported better-than-expected results for its fourth quarter and raised its quarterly dividend from $0.10 to $0.12 per share.
    • Applied Digital Corporation (NASDAQ:APLD) rose 15.8% to $11.20 after the company announced its AI cloud service has secured a second AI customer with an agreement worth up to $460 million over 36 months.
    • Leafly Holdings, Inc. (NASDAQ:LFLY) gained 13.2% to $0.32.
    • Appreciate Holdings, Inc. (NASDAQ:SFR) jumped 11.7% to $0.38.
    • Trupanion, Inc. (NASDAQ:TRUP) gained 10.4% to $22.71 after California and New York approved the company's requested rate increases.
    • CarMax, Inc. (NYSE:KMX) jumped 10% to $86.14 after the company reported better-than-expected first-quarter EPS and sales results.
    • TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares gained 9.4% to $7.99. Superlatus, Inc. signed a binding letter of intent to be acquired by TRxADE HEALTH.
    • Apogee Enterprises, Inc. (NASDAQ:APOG) rose 8.4% to $47.48 following upbeat quarterly results.
    • Lifetime Brands, Inc. (NASDAQ:LCUT) gained 8.3% to $4.99 after adding around 5% on Thursday.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) climbed 8.1% to $2.14 after the company announced it has been awarded a contract with Petrobras to develop and test the AUV Aquanaut in Brazil.
    • VIQ Solutions Inc. (NASDAQ:VQS) shares climbed 7.8% to $0.3320 after gaining 4% on Thursday.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 7.8% to $0.7598 after gaining 12% on Thursday.
    • The Hain Celestial Group, Inc. (NASDAQ:HAIN) gained 6.3% to $12.69. Stephens & Co. analyst Jim Salera initiated coverage on Hain Celestial Group with an Overweight rating and announced a price target of $17.
    • GSK plc (NYSE:GSK) rose 5.9% to $36.72 in pre-market trading after the company settled a lawsuit alleging Its Zantac drug caused cancer, the trial will be dismissed.

    Losers

    • Spark Networks SE (NYSE:LOV) fell 60% to $0.2950. On June 21, Spark Networks got notice from Nasdaq Advising Co that Nasdaq has determined to deny the company’s request for continued listing on Nasdaq.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) dropped 58.6% to $0.1859 as the company reported pricing of $3.2 million public offering of 13,333,333 shares and warrants at a price of $0.24/share.
    • GSR II Meteora Acquisition Corp. (NASDAQ:GSRM) dropped 26.4% to $7.66.
    • Beyond Air, Inc. (NASDAQ:XAIR) shares fell 24% to $4.34 after the company posted a wider-than-expected fourth-quarter loss.
    • Skillz Inc. (NYSE:SKLZ) fell 19.3% to $0.4817. Skillz announced a 1-for-20 reverse stock split, effective June 23, 2023.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) fell 17.4% to $4.3950 after the company announced another at-the-market stock offering of $400 million to raise capital. The offering would be dilutive to shares.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) fell 16.6% to $0.0659.
    • Babylon Holdings Limited (NYSE:BBLN) dropped 16.1% to $0.5202 after the company agreed to be acquirred by AlbaCore Capital, MindMaze Group.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) fell 15.2% to $0.0670. Biodexa Pharmaceuticals announced 1 ADR for 400 ordinary share ratio change effective July 5, 2023.
    • Natuzzi S.p.A. (NYSE:NTZ) fell 14.7% to $6.38.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) fell 12.4% to $13.35. Jazz Pharmaceuticals filed suit against the FDA for approving Avadel Pharmaceuticals Lumryz (sodium oxybate extended-release) for cataplexy or excessive daytime sleepiness in adult patients with narcolepsy.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) fell 12.5% to $5.62.
    • FOXO Technologies Inc. (NYSE:FOXO) dropped 12.4% to $0.3111.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) shares dropped 12.3% to $0.3853. Tempo Automation shares jumped 20% on Thursday after the company announced it secured a $7 million convertible promissory note facility, strengthening its financial position and providing capital for the Optimum acquisition.
    • Canopy Growth Corporation (NASDAQ:CGC) fell 11.5% to $0.5313 as the company said FY23 net revenue dropped 21%.
    • Cricut, Inc. (NASDAQ:CRCT) dropped 9.4% to $15.38.
    • Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) fell 9.3% to $3.40.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) fell 9.2% to $112.51. Evercore ISI Group downgraded Sarepta Therapeutics from Outperform to Neutral and announced a $139 price target. The FDA granted accelerated approval to closely watched Sarepta Therapeutics’ gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) in ambulatory pediatric patients aged 4 through 5 years with a confirmed mutation in the DMD gene.
    • Biofrontera Inc. (NASDAQ:BFRI) shares dropped 7.3% to $0.5263 after declining around 4% on Thursday.

     

    Now Read This: Ethereum Falls Below This Key Level; Stacks Becomes Top Loser

    Get the next $APLD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APLD
    $APOG
    $AVDL
    $BBLN

    CompanyDatePrice TargetRatingAnalyst
    Hain Celestial Group Inc.
    $HAIN
    3/16/2026$0.50Equal Weight → Underweight
    Barclays
    Lifetime Brands Inc.
    $LCUT
    2/13/2026$5.00Buy
    Roth Capital
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    Sarepta Therapeutics Inc.
    $SRPT
    1/28/2026$20.00Equal Weight
    Barclays
    GSK plc
    $GSK
    1/27/2026Neutral
    Citigroup
    Lifetime Brands Inc.
    $LCUT
    1/26/2026$3.50Buy → Hold
    Canaccord Genuity
    Applied Digital Corporation
    $APLD
    1/7/2026$99.00Buy
    Arete
    GSK plc
    $GSK
    1/6/2026Equal Weight → Underweight
    Barclays
    More analyst ratings

    $APLD
    $APOG
    $AVDL
    $BBLN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLD
    $APOG
    $AVDL
    $BBLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Flores William bought $8,900 worth of shares (10,000 units at $0.89), increasing direct ownership by 222% to 14,501 units (SEC Form 4)

    4 - Nauticus Robotics, Inc. (0001849820) (Issuer)

    11/26/25 10:46:20 AM ET
    $KITT
    Industrial Machinery/Components
    Industrials

    Director Oneil Mark F bought $499,807 worth of shares (10,816 units at $46.21), increasing direct ownership by 78% to 24,690 units (SEC Form 4)

    4 - CARMAX INC (0001170010) (Issuer)

    10/6/25 4:11:10 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Director Steenrod Mitchell D bought $91,140 worth of shares (2,000 units at $45.57), increasing direct ownership by 6% to 38,330 units (SEC Form 4)

    4 - CARMAX INC (0001170010) (Issuer)

    10/3/25 4:09:20 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $APLD
    $APOG
    $AVDL
    $BBLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hain Celestial downgraded by Barclays with a new price target

    Barclays downgraded Hain Celestial from Equal Weight to Underweight and set a new price target of $0.50

    3/16/26 8:35:18 AM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    Roth Capital initiated coverage on Lifetime Brands with a new price target

    Roth Capital initiated coverage of Lifetime Brands with a rating of Buy and set a new price target of $5.00

    2/13/26 9:51:55 AM ET
    $LCUT
    Industrial Machinery/Components
    Consumer Discretionary

    Kingsoft Cloud upgraded by Goldman with a new price target

    Goldman upgraded Kingsoft Cloud from Neutral to Buy and set a new price target of $15.60

    2/11/26 7:42:03 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    $APLD
    $APOG
    $AVDL
    $BBLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Li Yi

    3 - Kingsoft Cloud Holdings Ltd (0001795589) (Issuer)

    3/18/26 5:52:33 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Tian Kaiyan

    3 - Kingsoft Cloud Holdings Ltd (0001795589) (Issuer)

    3/18/26 5:52:29 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Qu Jingyuan

    3 - Kingsoft Cloud Holdings Ltd (0001795589) (Issuer)

    3/18/26 5:52:30 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    $APLD
    $APOG
    $AVDL
    $BBLN
    SEC Filings

    View All

    SEC Form 6-K filed by Biodexa Pharmaceuticals plc American Depositary Shs

    6-K - Biodexa Pharmaceuticals Plc (0001643918) (Filer)

    3/18/26 5:11:41 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/18/26 12:50:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/18/26 8:42:38 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLD
    $APOG
    $AVDL
    $BBLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ADR Ratio Change

    March 18, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") ADR Ratio Change Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with unmet medical needs, today announces a ratio change on its American Depositary Receipts ("ADR") from one (1) ADR representing one hundred thousand (100,000) ordinary shares, to the new ratio of one (1) ADR representing five hundred thousand (500,000) ordinary shares (the "Ratio Change"). The effective date of the Ratio Change is expected to be on or about April 6, 2026. Pursuant to the Ratio Change, ADR holders will be required on a

    3/18/26 5:00:00 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuvve Expands European Revenue Platform with New 40MW Austrian BESS Project Under OMNIA Cooperation Agreement

    Nuvve to earn consulting and grid aggregation fees on 40 MW / 80 MWh project in Austria, with a right of first refusal to acquire the completed asset; combined European BESS pipeline now could represent annual revenue potential exceeding four times Nuvve's FY2024 revenues Nuvve Holding Corp. (NASDAQ:NVVE), a global leader in grid modernization, vehicle-to-grid (V2G) technology and grid-interactive energy solutions, today announced the addition of a 40 MW / 80 MWh battery energy storage system (BESS) project in Austria to the joint European energy platform it is building with OMNIA Group Holdings (Zug, Switzerland). The project — developed through the Austrian SPV Energiepark Graphit GmbH

    3/16/26 9:00:00 AM ET
    $NVVE
    Electrical Products
    Industrials

    Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

    - Approximately 25 non-ambulatory participants will receive sirolimus as part of the regimen in Cohort 8 of the ENDEAVOR study - The enhanced immunosuppressive regimen is designed to mitigate the risk of acute liver injury (ALI) and acute liver failure (ALF) associated with AAV gene therapy in non-ambulatory patients Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced screening and enrollment are underway in Cohort 8 of ENDEAVOR (Study 9001-103). The purpose of Cohort 8 is to assess prophylactic sirolimus treatment as part of an enhanced safety protocol during treatment with ELEVIDYS (delandistrogene moxeparvovec-rokl) in

    3/16/26 8:33:00 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APLD
    $APOG
    $AVDL
    $BBLN
    Financials

    Live finance-specific insights

    View All

    Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

    Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed's POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform's clinical development Provides Lifeward access to up to $47 million of capital HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that its shareholders approved the issuances of ordinary shares of the Company in connection with closing of the Co

    3/13/26 8:00:00 AM ET
    $LFWD
    $ORMP
    Industrial Specialties
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Lifetime Brands, Inc. Reports Fourth Quarter 2025 Financial Results

    Declares Regular Quarterly Dividend GARDEN CITY, N.Y., March 12, 2026 (GLOBE NEWSWIRE) -- Lifetime Brands, Inc. (NASDAQ:LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today reported its financial results for the quarter and full year ended December 31, 2025. Rob Kay, Lifetime's Chief Executive Officer, commented, "Our fourth quarter results reflect the culmination of several strategic decisions made earlier in the year, decisions that were not without short-term cost, but right for the business. We moved first on pricing to offset tariff headwinds, partnered closely with our customers to navigate a period of real d

    3/12/26 7:00:00 AM ET
    $LCUT
    Industrial Machinery/Components
    Consumer Discretionary

    Kingsoft Cloud to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 25, 2025

    BEIJING, March 9, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited (NASDAQ:KC) ("Kingsoft Cloud" or the "Company"), a leading cloud service provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2025 ended December 31, 2025 before the open of U.S. markets on Wednesday, March 25, 2025. Kingsoft Cloud's management will host an earnings conference call on Wednesday March 25, 2025 at 8:15 am, U.S. Eastern Time (8:15 pm, Beijing/Hong Kong Time on the same day).Preregistration InformationParticipants can register for the conference call by navigating to https://register-conf.media-server.com/register/BI62cd2e3d362448ba8a49

    3/10/26 7:00:00 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    $APLD
    $APOG
    $AVDL
    $BBLN
    Leadership Updates

    Live Leadership Updates

    View All

    Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Strengthens Canopy Growth's core Canadian platform, providing additional high-quality flower to support international growth Expected run-rate synergies of approximately $10 million within 18 months Canopy Growth's leadership team and operational depth strengthened through addition of MTL management team members Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) and MTL Cannab

    3/16/26 7:41:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Starboard Delivers Letter to CarMax

    Views Appointment of New CEO Keith Barr as Timely Opportunity to Address Fixable Execution Gaps and Unlock CarMax's Full Value Potential Has Nominated Directors to Help Support the Next Phase of Execution and Accelerate Shareholder Value Creation Believes CarMax's Structurally Superior Omnichannel Model Is Not Reflected in Current Performance Sees Clear Opportunities to Drive Improvement Through Enhanced Digital Execution, Reconditioning Efficiencies and Dynamic Pricing Urges a Substantially Expanded SG&A Reduction Program to Restore Cost Discipline and Enhance Long-Term Earnings Power Starboard Value LP (together with its affiliates, "Starboard"), a significant stockholder of Car

    3/11/26 8:00:00 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Ordinary Shareholders' Meeting of Natuzzi S.p.A.

    ― Resolution of appropriate measures pursuant to Article 2446 of the Italian Civil Code ― Ratification of the appointment of non-executive director Natuzzi S.p.A. (NYSE:NTZ) ("Natuzzi" or the "Company") today announced that its ordinary shareholders' meeting (the "Shareholders' Meeting"), convened on second call, was held on February 16, 2026. The Shareholders' Meeting resolved to postpone the decision regarding the reduction of the Company's share capital pursuant to Article 2446 of the Italian Civil Code, following the losses recorded in the Company's unaudited financial statements for the first nine months and the third quarter ended September 30, 2025, to the shareholders' meeting

    2/17/26 4:30:00 PM ET
    $NTZ
    Home Furnishings
    Consumer Discretionary

    $APLD
    $APOG
    $AVDL
    $BBLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pieris Pharmaceuticals Inc.

    SC 13G/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Subject)

    12/17/24 5:42:35 PM ET
    $PIRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Skillz Inc.

    SC 13D/A - Skillz Inc. (0001801661) (Subject)

    12/12/24 4:01:36 PM ET
    $SKLZ
    EDP Services
    Technology

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    12/5/24 7:17:43 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary